Yüklüyor......

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ecancermedicalscience
Asıl Yazarlar: Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cancer Intelligence 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462884/
https://ncbi.nlm.nih.gov/pubmed/26082801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.544
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!